Cipla Gets USFDA Approval for Asthma Inhalation Drug Amid Rising Demand Due to Covid-19 Crisis

The US Food and Drug Administration approved Indian drugmaker Cipla Ltd to make the generic version of albuterol sulfate-based inhaler in a bid to help patients suffering from the coronavirus.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.